Marinus Pharmaceuticals Announces Topline Results from Phase 3 RAISE Trial of IV Ganaxolone in Refractory Status EpilepticusBusiness Wire • 06/17/24
MRNS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Marinus Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • 06/16/24
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Marinus Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – MRNSGlobeNewsWire • 06/16/24
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Marinus Pharmaceuticals, Inc. (MRNS) InvestorsBusiness Wire • 06/14/24
Marinus Pharmaceuticals, Inc. Stockholders with Large Losses Should Contact Robbins LLP About Their Rights in Connection with the MRNS Class Action LawsuitBusiness Wire • 06/14/24
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Marinus Pharmaceuticals, Inc. (MRNS) InvestorsBusiness Wire • 06/13/24
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Marinus Pharmaceuticals, Inc. (MRNS) on Behalf of InvestorsBusiness Wire • 06/13/24
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Marinus Pharmaceuticals, Inc. (MRNS) on Behalf of InvestorsBusiness Wire • 06/13/24
Investigation Into Claims Against Marinus Pharmaceuticals, Inc. Is Initiated By The Schall Law Firm And Investors Who Have Suffered Losses Are Encouraged To Make ContactAccesswire • 06/12/24
The Law Offices of Frank R. Cruz Announces Investigation of Marinus Pharmaceuticals, Inc. (MRNS) on Behalf of InvestorsBusiness Wire • 06/12/24
The Schall Law Firm Initiates Investigation Into Claims Against Marinus Pharmaceuticals, Inc. And Encourages Investors Who Have Incurred Losses To Reach OutAccesswire • 06/11/24
The Schall Law Firm Starts Probe Into Claims Against Marinus Pharmaceuticals, Inc. And Invites Investors Who Have Suffered Losses To Make ContactAccesswire • 06/11/24
MRNS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Marinus Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitAccesswire • 06/11/24
MRNS Class Action Alert: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Class Action Against Marinus Pharmaceuticals, Inc.GlobeNewsWire • 06/11/24
MARINUS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Marinus Pharmaceuticals, Inc. and Encourages Investors to Contact the FirmGlobeNewsWire • 06/11/24
ROSEN, A LONGSTANDING LAW FIRM, Encourages Marinus Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – MRNSGlobeNewsWire • 06/11/24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Marinus Pharmaceuticals, Inc. - MRNSAccesswire • 06/09/24
The Schall Law Firm Initiates Investigation Into Claims Against Marinus Pharmaceuticals, Inc. And Encourages Investors With Losses To Contact ThemAccesswire • 06/09/24
The Schall Law Firm Has Started Looking Into Allegations Against Marinus Pharmaceuticals, Inc. And Is Urging Investors Who Have Experienced Losses To Reach Out To ThemAccesswire • 06/08/24
The Schall Law Firm Begins Probe Into Accusations Against Marinus Pharmaceuticals, Inc. And Invites Investors Who Have Suffered Losses To ConnectAccesswire • 06/08/24
Marinus Pharmaceuticals Investor Notice: Robbins LLP Reminds Stockholders to Seek Representation in the MRNS Class ActionBusiness Wire • 06/07/24
The Schall Law Firm Begins Inquiry Into Claims Against Marinus Pharmaceuticals, Inc. And Encourages Investors With Losses To Contact ThemAccesswire • 06/07/24
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Marinus Pharmaceuticals, Inc. with Losses to Contact the FirmBusiness Wire • 06/07/24
MARINUS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Marinus Pharmaceuticals, Inc. and Encourages Investors to Contact the FirmGlobeNewsWire • 06/07/24
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Marinus Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - MRNSPRNewsWire • 06/07/24
